ZYDUS WELLNESS LTD.-$ - 531335 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release dated May 17, 2023 proposed to be published in the newspapers in the matter of audited financial results for the quarter / year ended on March 31, 2023 ZYDUS WELLNESS LTD.-$ - 531335 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation ZYDUS WELLNESS LTD.-$ - 531335 - Corporate Action-Board approves Dividend
The Board of Directors at their meeting held today have recommended Final Dividend of Rs. 5.00/- (@ 50%) per equity share of Rs. 10/- each, subject to approval of the members at the ensuing Annual General Meeting scheduled to be held on August 3, 2023. ZYDUS WELLNESS LTD.-$ - 531335 - Board Meeting Outcome for Audited Financial Results For The Year Ended On March 31, 2023
Outcome of Board Meeting ZYDUS WELLNESS LTD.-$ - 531335 - Audited Financial Results For The Year Ended March 31, 2023
Outcome of Board Meeting ZYDUS WELLNESS LTD.-$ - 531335 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of Analyst / Institutional Investors' call ZYDUS WELLNESS LTD.-$ - 531335 - Board Meeting Intimation for Approval Of Audited Financial Results For The Quarter / Year Ended On March 31, 2023 And To Recommend Final Dividend For The Financial Year Ended On March 31, 2023
ZYDUS WELLNESS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/05/2023 ,inter alia, to consider and approve audited financial results for the quarter / year ended on March 31, 2023 and to recommend final dividend for the financial year ended on March 31, 2023
Zydus Lifesciences gets final approval from USFDA to manufacture ulcer drug
Sucralfate Tablets USP, 1 gram had annual sales of $84 million in the United States ZYDUS WELLNESS LTD.-$ - 531335 - Reporting Of Violation Of Code Of Conduct Under SEBI (Prohibition Of Insider Trading) Regulations, 2015 ('SEBI PIT Regulations')
In terms of SEBI circular no. SEBI/HO/ISD/ISD/CIR/P/2020/135 dated July 23, 2020 ("SEBI Circular") with respect to reporting to the Stock Exchanges regarding violations under SEBI PIT Regulations relating to the Code of Conduct ('CoC'), please find attached herewith report of the Company for violation of CoC by one of its Designated Persons.